Tuesday, 20 Nov 2018

You are here

Dr. Len Calabrese - EULAR 2018 Vasculitis Update on C5a Receptor Inhibitor

EULAR studies on avacopan (CCX168), an oral selective C5a receptor inhibitor

Add new comment

Want to talk about this video? Comment here to lead the discussion.
MORE VIDEOS

Dr. Rafid Asfar: Granulomatosis with...

19 May 2016

The RheumNow Week in Review – 28...

28 Oct 2016

Dr. Gardiner: Vasculitis

23 Oct 2018

Dr. Irwin Lim: Checkpoint Inhibitors

06 Nov 2017

Dr. Jack Cush at EULAR 2018 - DECT...

14 Jun 2018

Dr. Julio Gonzalez: Psoriatic Arthritis...

07 Nov 2017

The RheumNow Week in Review – 6 January...

06 Jan 2017

Dr. Arthur Kavanaugh: Psoriatic...

11 Feb 2018

Dr. Cush: Best Thing I Saw Today in PsA

25 Oct 2018

Alvin Wells, MD: JAK Inhibitors, Other...

08 Nov 2015

Dr. Philip Robinson: Osteoarthritis and...

08 Nov 2017

The RheumNow Week in Review - 20...

20 Oct 2017